Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C–Related Hepatocellular Carcinoma

2007134 citationsJournal Article

Authors

Kazuki Ikeda · Japanese Red Cross Society Wakayama Medical Center

Hiroyuki Marusawa · Japanese Red Cross Society Wakayama Medical Center

Yukio Osaki · Kyoto University

Takefumi Nakamura · Japanese Red Cross Society Wakayama Medical Center

Naoto Kitajima · Kansai Electric Power (Japan)

Yukitaka Yamashita · Kansai Electric Power (Japan)

Masatoshi Kudo

Abstract

Anti-HBc-positive results on serologic testing are a marker of high risk for HCC among patients with HCV-related cirrhosis. Interferon therapy might be less effective in preventing HCC among patients with chronic hepatitis C who are anti-HBc-positive than in those with chronic hepatitis C who are anti-HBc-negative.

Topics & Keywords

Hepatitis C virus research Hepatitis B Virus Studies Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 146, Issue 9, pp. 649-656

DOI: 10.7326/0003-4819-146-9-200705010-00008

Field-Weighted Citation Impact: 8.86

Command Palette